IP Library Granted Patent US 8,673,353
Granted Patent B2
US 8,673,353 · App. 12/866,999 · Granted Mar 18, 2014

Tablet having improved elution properties

Inventors: Makiko Yanagida (Ibaraki, JP); Hiroyuki Nishii (Ibaraki, JP); Masayuki Nakazono (Ibaraki, JP)
Assignee: Dainippon Sumitomo Pharma Co., Ltd
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,673,353
App. No.
12/866,999
Granted
Mar 18, 2014
Kind
B2
Abstract

The present invention provides a tablet having improved dissolution property, which comprises (+)-3-{1-[3-(trifluoromethoxy)benzyl]piperidin-4-yl}-4-phenyl-3,4-dihydro-2(1H)-quinazolinone or a pharmaceutically acceptable salt thereof as an active component, and a production method thereof. A film-coated tablet obtained by mixing granulated particles obtained by granulating a mixture containing (a) the aforementioned active component, (b) one or more kinds of fillers selected from lactose, D-mannitol, erythritol and crystalline cellulose, (c) a cellulose-based disintegrant and (d) a water-soluble binder with a later powder containing (e) one or more kinds of fillers selected from lactose, D-mannitol and crystalline cellulose and/or (f) a cellulose-based disintegrant, forming the mixture, and applying film coating. A production method of a film-coated tablet, including a step of producing the granulated particles, a step of producing a tablet by mixing with the later powder and forming the mixture, and a step of applying a film coating to the obtained tablet.

Claims (23)

1. A film-coated tablet obtained by mixing granulated particles obtained by granulating a mixture of (a)(+)-3-{1-[3-(trifluoromethoxy)benzyl]piperidin-4-yl}-4-phenyl-3,4-dihydro-2(1H)-quinazolinone or a pharmaceutically acceptable salt thereof, (b) one or more kinds of fillers selected from lactose, D-mannitol, erythritol and crystalline cellulose, (c) a cellulose-based disintegrant and (d) a water-soluble binder, and mixing the resulting granulated particles with (e) one or more kinds of fillers selected from lactose, D-mannitol and crystalline cellulose and/or (f) a cellulose-based disintegrant, forming the mixture to give a tablet and applying film coating to the tablet.

2. The film-coated tablet according to claim 1 , wherein the filler of the aforementioned (b) is one or more kinds of fillers selected from lactose, D-mannitol and crystalline cellulose.

3. The film-coated tablet according to claim 1 , which is obtained by mixing granulated particles obtained by granulating a mixture of (a)(+)-3-{1-[3-(trifluoromethoxy)benzyl]piperidin-4-yl}-4-phenyl-3,4-dihydro-2(1H)-quinazolinone or a pharmaceutically acceptable salt thereof, the filler(s) of (b), (c) a cellulose-based disintegrant and (d) a water-soluble binder, with (e) one or more kinds of fillers selected from lactose, D-mannitol and crystalline cellulose and (f) a cellulose-based disintegrant, forming the mixture to give a tablet and applying film coating to the tablet.

4. The film-coated tablet according to claim 1 , wherein the fillers of the aforementioned (b) and (e) are the same or different and one or more kinds selected from lactose and D-mannitol.

5. The film-coated tablet according to claim 4 , wherein the fillers of the aforementioned (b) and (e) are lactose.

6. The film-coated tablet according to claim 1 , wherein the cellulose-based disintegrants of the aforementioned (c) and (f) are the same or different and one or more kinds selected from carmellose calcium, low-substituted hydroxypropylcellulose and croscarmellose sodium.

7. The film-coated tablet according to claim 6 , wherein the cellulose-based disintegrants of the aforementioned (c) and (f) are the same or different and one or more kinds selected from carmellose calcium and low-substituted hydroxypropylcellulose.

8. The film-coated tablet according to claim 6 , wherein the cellulose-based disintegrant of the aforementioned (f) comprises carmellose calcium and low-substituted hydroxypropylcellulose.

9. The film-coated tablet according to claim 1 further comprising starch.

10. The film-coated tablet according to claim 9 , wherein the starch is natural starch.

11. The film-coated tablet according to claim 9 , wherein the starch is corn starch.

12. The film-coated tablet according to claim 1 , wherein the water-soluble binder is one or more kinds selected from polyvinyl alcohol, hydroxypropylcellulose and hypromellose 2910.

13. The film-coated tablet according to claim 12 , wherein the water-soluble binder is one or more kinds selected from polyvinyl alcohol and hydroxypropylcellulose.

14. The film-coated tablet according to claim 12 , wherein the water-soluble binder is polyvinyl alcohol.

15. The film-coated tablet according to claim 1 , wherein the filler of the aforementioned (b) is lactose, the cellulose-based disintegrant of the aforementioned (c) is one or more kinds selected from carmellose calcium and low-substituted hydroxypropylcellulose, the water-soluble binder of the aforementioned (d) is one or more kinds selected from polyvinyl alcohol and hydroxypropylcellulose, the filler of the aforementioned (e) is lactose, and the cellulose-based disintegrant of the aforementioned (f) is one or more kinds selected from carmellose calcium and low-substituted hydroxypropylcellulose.

16. The film-coated tablet according to claim 15 , further comprising starch.

17. The film-coated tablet according to any one of claims 1 to 16 , showing a 15 min value of not less than 75% when the dissolution property is evaluated according to the Japanese Pharmacopeia, 15 th edition, Dissolution Test Method (Paddle Method) and using, diluted McIlvaine buffer adjusted to pH 5.0 as a test solution at rotation number 50 rpm.

18. A method of producing a film-coated tablet, comprising the following steps:

(1) a step of producing granulated particles by granulating a mixture containing (a)(+)-3-{1-[3-(trifluoromethoxy)benzyl]piperidin-4-yl}-4-phenyl-3,4-dihydro-2(1H)-quinazolinone or a pharmaceutically acceptable salt thereof, (b) one or more kinds of fillers selected from lactose, D-mannitol, erythritol and crystalline cellulose, (c) a cellulose-based disintegrant and (d) a water-soluble binder;

(2) a step of producing a tablet by mixing the granulated particles obtained in step (1) with (e) one or more kinds of fillers selected from lactose, D-mannitol and crystalline cellulose and/or (f) a cellulose-based disintegrant, and forming the mixture; and

(3) a step of applying a film coating to the tablet obtained in step (2).

19. The production method according to claim 18 , wherein the filler of the aforementioned (b) is one or more kinds of fillers selected from lactose, D-mannitol and crystalline cellulose.

20. The production method according to claim 18 , wherein the filler of the aforementioned (b) is lactose, the cellulose-based disintegrant of the aforementioned (c) is one or more kinds selected from carmellose calcium and low-substituted hydroxypropylcellulose, the water-soluble binder of the aforementioned (d) is one or more kinds selected from polyvinyl alcohol and hydroxypropylcellulose, the filler of the aforementioned (e) is lactose, and the cellulose-based disintegrant of the aforementioned (f) is one or more kinds selected from carmellose calcium and low-substituted hydroxypropylcellulose.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2010
From: YANAGIDA, MAKIKO; NISHII, HIROYUKI; NAKAZONO, MASAYUKI
To: DAINIPPON SUMITOMO PHARMA CO., LTD.
Reel/Frame 025155/0014 →
Continuity (2)
Provisional Application 61064012 · Feb 11, 2008
Related Publication 20110027362A1 · Feb 3, 2011